Australia’s industry body for biotechnology, AusBiotech, has announced ex-Sanofi leader Rebekah Cassidy as its incoming Chief Executive Officer (CEO).

Rebekah is an experienced leader with extensive strategy, policy, and media proficiency, coupled with deep health industry expertise. 

Previously holding leadership roles in some of Australia’s largest corporations, for global organisations and in government, she is recognised for her ability to navigate complex stakeholder environments, forge trusted strategic partnerships, and drive meaningful change.

Most recently Sanofi’s Deputy Head of Corporate Affairs and Sustainability, Australia & New Zealand, Rebekah brings experience from companies working at the bench through to bedside, including The Royal Melbourne Hospital, and her broad experience has aided her understanding of Australia’s health ecosystem and the value the life sciences sector brings to Australia.

Interim Chair Dr James Campbell led the Board's welcome, “Rebekah’s policy and stakeholder expertise, coupled with her track record in transparent and inclusive leadership and her clear passion for amplifying an aligned voice for life sciences in Australia, made her a standout candidate. The Board and I are looking forward to supporting Rebekah as she leads a new way forward for our committed AusBiotech team.”